Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphocyte-Rich Classical Hodgkin Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00666484
What this trial is testing

Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma

Who this might be right for
LymphomaNeurotoxicity
University College, London 47
Not applicableStudy completedNCT00305149
What this trial is testing

Risk Adapted Beacopp Regimen for Standard and High Risk Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin LymphomaNodular SclerosisMixed Cellularity+2 more
Rambam Health Care Campus 130
Testing effectiveness (Phase 2)UnknownNCT03226249
What this trial is testing

PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin LymphomaLymphocyte-Depleted Classical Hodgkin LymphomaLymphocyte-Rich Classical Hodgkin Lymphoma+2 more
Northwestern University 30
Testing effectiveness (Phase 2)Ended earlyNCT00288067
What this trial is testing

Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Adult Nodular Lymphocyte Predominant Hodgkin LymphomaB-cell Chronic Lymphocytic LeukemiaContiguous Stage II Adult Burkitt Lymphoma+57 more
National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Ended earlyNCT00112723
What this trial is testing

Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+25 more
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Study completedNCT00132028
What this trial is testing

Vorinostat in Treating Patients With Relapsed or Refractory Advanced Hodgkin's Lymphoma

Who this might be right for
Adult Favorable Prognosis Hodgkin LymphomaAdult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin Lymphoma+5 more
National Cancer Institute (NCI) 27
Early research (Phase 1)Study completedNCT00439361
What this trial is testing

Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaLymphoma
M.D. Anderson Cancer Center 14
Testing effectiveness (Phase 2)Study completedNCT00742027
What this trial is testing

Phase II Study of Oral Panobinostat in Adult Participants With Relapsed/Refractory Classical Hodgkin's Lymphoma

Who this might be right for
Classical Hodgkin's Lymphoma
Novartis Pharmaceuticals 129
Early research (Phase 1)Study completedNCT01588015
What this trial is testing

Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+123 more
City of Hope Medical Center 36
Testing effectiveness (Phase 2)Study completedNCT00822120
What this trial is testing

S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma

Who this might be right for
LymphomaNonneoplastic Condition
SWOG Cancer Research Network 371
Not applicableStudy completedNCT01366157
What this trial is testing

Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin Lymphoma

Who this might be right for
Lymphoma
Children's Oncology Group 23
Large-scale testing (Phase 3)Study completedNCT00678327
What this trial is testing

Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma

Who this might be right for
Lymphoma
University College, London 1,202
Not applicableLooking for participantsNCT06098430
What this trial is testing

Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

Who this might be right for
Nodular Lymphocyte-Predominant Hodgkin Lymphoma
St. Jude Children's Research Hospital 100
Testing effectiveness (Phase 2)Study completedNCT01460940
What this trial is testing

A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+3 more
Ohio State University Comprehensive Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT00006760
What this trial is testing

Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Children's Oncology Group 66
Large-scale testing (Phase 3)UnknownNCT00041210
What this trial is testing

Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Mount Vernon Cancer Centre at Mount Vernon Hospital 850
Testing effectiveness (Phase 2)Study completedNCT01118026
What this trial is testing

Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 101
Testing effectiveness (Phase 2)Looking for participantsNCT05886036
What this trial is testing

Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial

Who this might be right for
Nodular Lymphocyte Predominant B-Cell LymphomaRecurrent Nodular Lymphocyte Predominant B-Cell LymphomaRefractory Nodular Lymphocyte Predominant B-Cell Lymphoma
National Cancer Institute (NCI) 70
Large-scale testing (Phase 3)Study completedNCT01026220
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma

Who this might be right for
Childhood Nodular Lymphocyte Predominant Hodgkin LymphomaStage III Childhood Hodgkin LymphomaStage IV Childhood Hodgkin Lymphoma
Children's Oncology Group 166
Testing effectiveness (Phase 2)Study completedNCT01187303
What this trial is testing

Ofatumumab in Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL)

Who this might be right for
Relapsed NLPHL
University of Cologne 28
Next Page